Clinical trial
Benchmarking AI for Clinical Oncology decisioNmaking (BEACON): A Prospective, Multicentre, Blinded Evaluation of Frontier Large Language Models Against Multidisciplinary Tumour Board Recommendations in Oncology Treatment Planning
NCT07739121 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benchmarking AI for Clinical Oncology decisioNmaking (BEACON): A Prospective, Multicentre, Blinded Evaluation of Frontier Large Language Models Against Multidisciplinary Tumour Board Recommendations in Oncology Treatment Planning
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2026
- Completion date
- March 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
artifical intelligence, breast neoplasms, decision making, decision support systems, clinical, digestive system neoplasms, genital neoplasms, kidney neoplasms, large language models, lung neoplasms, prostatic neoplasms, urinary bladder neoplasms, urologic neoplasms